Zimmer Biomet Holdings Stock Math Operators Price Series Multiplication

ZBH Stock

USD 93.22 0.63 0.68%

The math operators module provides an execution environment for Price Series Multiplication operator and related indicators on Zimmer Biomet and United Therapeutics. The analysis highlights relative price relationships between Zimmer Biomet and United Therapeutics and frames technical signals with volatility and risk context.

Symbols

Operator

The output start index for this execution was zero with a total number of output elements of sixty-one. Zimmer Biomet Holdings Price Series Multiplication is a cross multiplication of Zimmer Biomet price series and its benchmark/peer.

Zimmer Biomet Technical Analysis Modules

Most technical analysis of Zimmer Biomet help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zimmer from various momentum indicators to cycle indicators. When you analyze Zimmer charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Zimmer Biomet operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 19500 people. This stock section frames Zimmer Biomet within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/E of 77.41, P/B of 1.44, profit margin of 8.57%. Zimmer Biomet has a market cap of 18.58 B, P/E of 77.41, ROE of 5.6%.

Methodology

Unless otherwise specified, financial data for Zimmer Biomet Holdings is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Zimmer (USA Stocks:ZBH) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Zimmer Biomet Holdings is covered by 29 analysts. 14 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Bernstein Research, Deutsche Bank, Morgan Stanley, BMO Capital Markets, Guggenheim Securities, Jefferies, Goldman Sachs, Evercore ISI, Raymond James, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zimmer Biomet in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zimmer Biomet's short interest history, or implied volatility extrapolated from Zimmer Biomet options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
C	Citigroup
WD	Walker Dunlop

More Resources for Zimmer Stock Analysis

A structured review of Zimmer Biomet Holdings often starts with core financial statements and trend context. Ratio context helps frame profitability, efficiency, and growth trends for Zimmer Biomet Holdings Stock. Highlighted below are reports that provide context for Zimmer Biomet Holdings Stock:

How To Invest In Zimmer

Details

Is Zimmer Stock a good investment?

Details

What is Zimmer Biomet's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Zimmer Biomet has a market cap of 18.58 B, operating margin of 13.97%, ROE of 5.6%. Use Your Current Watchlist to explore allocation context. This includes a position in Zimmer Biomet Holdings inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Analysis related to Zimmer Biomet should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Holdings module to check your current holdings and cash position to determine if your portfolio needs rebalancing.

Quarterly Earnings Growth

-0.41

Dividend Share

0.96

Earnings Share

3.55

Revenue Per Share

41.573

Quarterly Revenue Growth

0.109

The market value of Zimmer Biomet Holdings is measured differently than book value, which reflects Zimmer accounting equity. Zimmer Biomet's market capitalization is 18.58 B. A P/B ratio of 1.44 indicates the market values Zimmer Biomet above its accounting book value. Enterprise value stands at 25.27 B. Intrinsic value reflects what Zimmer Biomet's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.

Note that Zimmer Biomet's intrinsic value and market price are different measures derived from different inputs. For Zimmer Biomet, key inputs include a P/E ratio of 77.41, a P/B ratio of 1.44, a profit margin of 8.57%, and ROE of 5.6%. The quoted price is simply the exchange level where supply meets demand.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Zimmer Biomet Holdings Stock Math Operators Price Series Multiplication

Zimmer Biomet Technical Analysis Modules

Stock Overview, Methodology & Data Sources

Methodology

Analyst Sources

This content is curated and reviewed by:

Also Currently Popular

More Resources for Zimmer Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY